KPIs & Operating Metrics(New)

Morgan Stanley (MS) Research & Development (2016 - 2025)

Morgan Stanley (MS) has disclosed Research & Development for 17 consecutive years, with $1.2 billion as the latest value for Q4 2025.

  • On a quarterly basis, Research & Development rose 9.54% to $1.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $4.4 billion, a 8.07% increase, with the full-year FY2025 number at $4.4 billion, up 8.07% from a year prior.
  • Research & Development was $1.2 billion for Q4 2025 at Morgan Stanley, up from $1.1 billion in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $1.2 billion in Q4 2025 to a low of $733.0 million in Q1 2021.
  • A 5-year average of $944.6 million and a median of $940.0 million in 2022 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: skyrocketed 30.2% in 2021, then increased 5.79% in 2023.
  • Morgan Stanley's Research & Development stood at $833.0 million in 2021, then grew by 12.0% to $933.0 million in 2022, then grew by 5.79% to $987.0 million in 2023, then increased by 7.29% to $1.1 billion in 2024, then rose by 9.54% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for MS's Research & Development are $1.2 billion (Q4 2025), $1.1 billion (Q3 2025), and $1.1 billion (Q2 2025).